Neuroendocrine
DiscoveriesAnti-cancer drug shows incredible promise in phase 1 human clinical trials
A clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with cancers.
Joseph Shavit